The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Methylphenidate Extended Release Tablets Market Research Report 2025
Synopsis
Methylphenidate Extended Release Tablets are a form of medication primarily used to manage symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. This medication functions as a central nervous system stimulant and works by increasing the levels of certain neurotransmitters in the brain, which enhances attention and focus while reducing impulsive and hyperactive behavior. The extended-release formulation of methylphenidate is designed to gradually release the drug into the bloodstream over an extended period, typically providing symptom relief for about 8 to 12 hours. This allows for consistent therapeutic effects throughout the day with a reduced need for multiple doses. It is essential for this medication to be taken under the supervision of a healthcare provider, as it requires careful dosage adjustments and monitoring for potential side effects.
The global Methylphenidate Extended Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Methylphenidate Extended Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methylphenidate Extended Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Methylphenidate Extended Release Tablets in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Methylphenidate Extended Release Tablets include Johnson & Johnson, Novartis, Tris Pharma, Lannett Company, Noven Pharmaceuticals, Purdue Parma, Mallinckrodt, Ironshore Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Methylphenidate Extended Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylphenidate Extended Release Tablets.
The Methylphenidate Extended Release Tablets market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methylphenidate Extended Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methylphenidate Extended Release Tablets companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Novartis
Tris Pharma
Lannett Company
Noven Pharmaceuticals
Purdue Parma
Mallinckrodt
Ironshore Pharmaceuticals
Segment by Type
18mg
27mg
36mg
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methylphenidate Extended Release Tablets company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Methylphenidate Extended Release Tablets are a form of medication primarily used to manage symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. This medication functions as a central nervous system stimulant and works by increasing the levels of certain neurotransmitters in the brain, which enhances attention and focus while reducing impulsive and hyperactive behavior. The extended-release formulation of methylphenidate is designed to gradually release the drug into the bloodstream over an extended period, typically providing symptom relief for about 8 to 12 hours. This allows for consistent therapeutic effects throughout the day with a reduced need for multiple doses. It is essential for this medication to be taken under the supervision of a healthcare provider, as it requires careful dosage adjustments and monitoring for potential side effects.
The global Methylphenidate Extended Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Methylphenidate Extended Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methylphenidate Extended Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Methylphenidate Extended Release Tablets in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Methylphenidate Extended Release Tablets include Johnson & Johnson, Novartis, Tris Pharma, Lannett Company, Noven Pharmaceuticals, Purdue Parma, Mallinckrodt, Ironshore Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Methylphenidate Extended Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylphenidate Extended Release Tablets.
The Methylphenidate Extended Release Tablets market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methylphenidate Extended Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methylphenidate Extended Release Tablets companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Novartis
Tris Pharma
Lannett Company
Noven Pharmaceuticals
Purdue Parma
Mallinckrodt
Ironshore Pharmaceuticals
Segment by Type
18mg
27mg
36mg
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methylphenidate Extended Release Tablets company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methylphenidate Extended Release Tablets Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 18mg
1.2.3 27mg
1.2.4 36mg
1.3 Market by Application
1.3.1 Global Methylphenidate Extended Release Tablets Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Methylphenidate Extended Release Tablets Market Perspective (2019-2030)
2.2 Global Methylphenidate Extended Release Tablets Growth Trends by Region
2.2.1 Global Methylphenidate Extended Release Tablets Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Methylphenidate Extended Release Tablets Historic Market Size by Region (2019-2024)
2.2.3 Methylphenidate Extended Release Tablets Forecasted Market Size by Region (2025-2030)
2.3 Methylphenidate Extended Release Tablets Market Dynamics
2.3.1 Methylphenidate Extended Release Tablets Industry Trends
2.3.2 Methylphenidate Extended Release Tablets Market Drivers
2.3.3 Methylphenidate Extended Release Tablets Market Challenges
2.3.4 Methylphenidate Extended Release Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Methylphenidate Extended Release Tablets Players by Revenue
3.1.1 Global Top Methylphenidate Extended Release Tablets Players by Revenue (2019-2024)
3.1.2 Global Methylphenidate Extended Release Tablets Revenue Market Share by Players (2019-2024)
3.2 Global Methylphenidate Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Methylphenidate Extended Release Tablets Revenue
3.4 Global Methylphenidate Extended Release Tablets Market Concentration Ratio
3.4.1 Global Methylphenidate Extended Release Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methylphenidate Extended Release Tablets Revenue in 2023
3.5 Global Key Players of Methylphenidate Extended Release Tablets Head office and Area Served
3.6 Global Key Players of Methylphenidate Extended Release Tablets, Product and Application
3.7 Global Key Players of Methylphenidate Extended Release Tablets, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Methylphenidate Extended Release Tablets Breakdown Data by Type
4.1 Global Methylphenidate Extended Release Tablets Historic Market Size by Type (2019-2024)
4.2 Global Methylphenidate Extended Release Tablets Forecasted Market Size by Type (2025-2030)
5 Methylphenidate Extended Release Tablets Breakdown Data by Application
5.1 Global Methylphenidate Extended Release Tablets Historic Market Size by Application (2019-2024)
5.2 Global Methylphenidate Extended Release Tablets Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Methylphenidate Extended Release Tablets Market Size (2019-2030)
6.2 North America Methylphenidate Extended Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Methylphenidate Extended Release Tablets Market Size by Country (2019-2024)
6.4 North America Methylphenidate Extended Release Tablets Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Methylphenidate Extended Release Tablets Market Size (2019-2030)
7.2 Europe Methylphenidate Extended Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Methylphenidate Extended Release Tablets Market Size by Country (2019-2024)
7.4 Europe Methylphenidate Extended Release Tablets Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Methylphenidate Extended Release Tablets Market Size (2019-2030)
8.2 Asia-Pacific Methylphenidate Extended Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Methylphenidate Extended Release Tablets Market Size by Region (2019-2024)
8.4 Asia-Pacific Methylphenidate Extended Release Tablets Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Methylphenidate Extended Release Tablets Market Size (2019-2030)
9.2 Latin America Methylphenidate Extended Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Methylphenidate Extended Release Tablets Market Size by Country (2019-2024)
9.4 Latin America Methylphenidate Extended Release Tablets Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Methylphenidate Extended Release Tablets Market Size (2019-2030)
10.2 Middle East & Africa Methylphenidate Extended Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Methylphenidate Extended Release Tablets Market Size by Country (2019-2024)
10.4 Middle East & Africa Methylphenidate Extended Release Tablets Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Methylphenidate Extended Release Tablets Introduction
11.1.4 Johnson & Johnson Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Methylphenidate Extended Release Tablets Introduction
11.2.4 Novartis Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Tris Pharma
11.3.1 Tris Pharma Company Details
11.3.2 Tris Pharma Business Overview
11.3.3 Tris Pharma Methylphenidate Extended Release Tablets Introduction
11.3.4 Tris Pharma Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.3.5 Tris Pharma Recent Development
11.4 Lannett Company
11.4.1 Lannett Company Company Details
11.4.2 Lannett Company Business Overview
11.4.3 Lannett Company Methylphenidate Extended Release Tablets Introduction
11.4.4 Lannett Company Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.4.5 Lannett Company Recent Development
11.5 Noven Pharmaceuticals
11.5.1 Noven Pharmaceuticals Company Details
11.5.2 Noven Pharmaceuticals Business Overview
11.5.3 Noven Pharmaceuticals Methylphenidate Extended Release Tablets Introduction
11.5.4 Noven Pharmaceuticals Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.5.5 Noven Pharmaceuticals Recent Development
11.6 Purdue Parma
11.6.1 Purdue Parma Company Details
11.6.2 Purdue Parma Business Overview
11.6.3 Purdue Parma Methylphenidate Extended Release Tablets Introduction
11.6.4 Purdue Parma Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.6.5 Purdue Parma Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Methylphenidate Extended Release Tablets Introduction
11.7.4 Mallinckrodt Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.7.5 Mallinckrodt Recent Development
11.8 Ironshore Pharmaceuticals
11.8.1 Ironshore Pharmaceuticals Company Details
11.8.2 Ironshore Pharmaceuticals Business Overview
11.8.3 Ironshore Pharmaceuticals Methylphenidate Extended Release Tablets Introduction
11.8.4 Ironshore Pharmaceuticals Revenue in Methylphenidate Extended Release Tablets Business (2019-2024)
11.8.5 Ironshore Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Methylphenidate Extended Release Tablets Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 18mg
Table 3. Key Players of 27mg
Table 4. Key Players of 36mg
Table 5. Global Methylphenidate Extended Release Tablets Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Methylphenidate Extended Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Methylphenidate Extended Release Tablets Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Methylphenidate Extended Release Tablets Market Share by Region (2019-2024)
Table 9. Global Methylphenidate Extended Release Tablets Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Methylphenidate Extended Release Tablets Market Share by Region (2025-2030)
Table 11. Methylphenidate Extended Release Tablets Market Trends
Table 12. Methylphenidate Extended Release Tablets Market Drivers
Table 13. Methylphenidate Extended Release Tablets Market Challenges
Table 14. Methylphenidate Extended Release Tablets Market Restraints
Table 15. Global Methylphenidate Extended Release Tablets Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Methylphenidate Extended Release Tablets Market Share by Players (2019-2024)
Table 17. Global Top Methylphenidate Extended Release Tablets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylphenidate Extended Release Tablets as of 2023)
Table 18. Ranking of Global Top Methylphenidate Extended Release Tablets Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Methylphenidate Extended Release Tablets Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Methylphenidate Extended Release Tablets, Headquarters and Area Served
Table 21. Global Key Players of Methylphenidate Extended Release Tablets, Product and Application
Table 22. Global Key Players of Methylphenidate Extended Release Tablets, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Methylphenidate Extended Release Tablets Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Methylphenidate Extended Release Tablets Revenue Market Share by Type (2019-2024)
Table 26. Global Methylphenidate Extended Release Tablets Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Methylphenidate Extended Release Tablets Revenue Market Share by Type (2025-2030)
Table 28. Global Methylphenidate Extended Release Tablets Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Methylphenidate Extended Release Tablets Revenue Market Share by Application (2019-2024)
Table 30. Global Methylphenidate Extended Release Tablets Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Methylphenidate Extended Release Tablets Revenue Market Share by Application (2025-2030)
Table 32. North America Methylphenidate Extended Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Methylphenidate Extended Release Tablets Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Methylphenidate Extended Release Tablets Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Methylphenidate Extended Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Methylphenidate Extended Release Tablets Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Methylphenidate Extended Release Tablets Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Methylphenidate Extended Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Methylphenidate Extended Release Tablets Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Methylphenidate Extended Release Tablets Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Methylphenidate Extended Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Methylphenidate Extended Release Tablets Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Methylphenidate Extended Release Tablets Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Methylphenidate Extended Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Methylphenidate Extended Release Tablets Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Methylphenidate Extended Release Tablets Market Size by Country (2025-2030) & (US$ Million)
Table 47. Johnson & Johnson Company Details
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Methylphenidate Extended Release Tablets Product
Table 50. Johnson & Johnson Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 51. Johnson & Johnson Recent Development
Table 52. Novartis Company Details
Table 53. Novartis Business Overview
Table 54. Novartis Methylphenidate Extended Release Tablets Product
Table 55. Novartis Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. Tris Pharma Company Details
Table 58. Tris Pharma Business Overview
Table 59. Tris Pharma Methylphenidate Extended Release Tablets Product
Table 60. Tris Pharma Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 61. Tris Pharma Recent Development
Table 62. Lannett Company Company Details
Table 63. Lannett Company Business Overview
Table 64. Lannett Company Methylphenidate Extended Release Tablets Product
Table 65. Lannett Company Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 66. Lannett Company Recent Development
Table 67. Noven Pharmaceuticals Company Details
Table 68. Noven Pharmaceuticals Business Overview
Table 69. Noven Pharmaceuticals Methylphenidate Extended Release Tablets Product
Table 70. Noven Pharmaceuticals Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 71. Noven Pharmaceuticals Recent Development
Table 72. Purdue Parma Company Details
Table 73. Purdue Parma Business Overview
Table 74. Purdue Parma Methylphenidate Extended Release Tablets Product
Table 75. Purdue Parma Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 76. Purdue Parma Recent Development
Table 77. Mallinckrodt Company Details
Table 78. Mallinckrodt Business Overview
Table 79. Mallinckrodt Methylphenidate Extended Release Tablets Product
Table 80. Mallinckrodt Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 81. Mallinckrodt Recent Development
Table 82. Ironshore Pharmaceuticals Company Details
Table 83. Ironshore Pharmaceuticals Business Overview
Table 84. Ironshore Pharmaceuticals Methylphenidate Extended Release Tablets Product
Table 85. Ironshore Pharmaceuticals Revenue in Methylphenidate Extended Release Tablets Business (2019-2024) & (US$ Million)
Table 86. Ironshore Pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Methylphenidate Extended Release Tablets Picture
Figure 2. Global Methylphenidate Extended Release Tablets Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Methylphenidate Extended Release Tablets Market Share by Type: 2023 VS 2030
Figure 4. 18mg Features
Figure 5. 27mg Features
Figure 6. 36mg Features
Figure 7. Global Methylphenidate Extended Release Tablets Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Methylphenidate Extended Release Tablets Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Methylphenidate Extended Release Tablets Report Years Considered
Figure 12. Global Methylphenidate Extended Release Tablets Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Methylphenidate Extended Release Tablets Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Methylphenidate Extended Release Tablets Market Share by Region: 2023 VS 2030
Figure 15. Global Methylphenidate Extended Release Tablets Market Share by Players in 2023
Figure 16. Global Top Methylphenidate Extended Release Tablets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylphenidate Extended Release Tablets as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Methylphenidate Extended Release Tablets Revenue in 2023
Figure 18. North America Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Methylphenidate Extended Release Tablets Market Share by Country (2019-2030)
Figure 20. United States Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Methylphenidate Extended Release Tablets Market Share by Country (2019-2030)
Figure 24. Germany Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Methylphenidate Extended Release Tablets Market Share by Region (2019-2030)
Figure 32. China Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Methylphenidate Extended Release Tablets Market Share by Country (2019-2030)
Figure 40. Mexico Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Methylphenidate Extended Release Tablets Market Share by Country (2019-2030)
Figure 44. Turkey Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Methylphenidate Extended Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Johnson & Johnson Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 49. Tris Pharma Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 50. Lannett Company Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 51. Noven Pharmaceuticals Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 52. Purdue Parma Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 53. Mallinckrodt Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 54. Ironshore Pharmaceuticals Revenue Growth Rate in Methylphenidate Extended Release Tablets Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
